Emerging Pharma and Biotech
Limited funding. Intense time pressures. Little experience or resources beyond the discovery phase. We understand the unique challenges faced by emerging pharmaceutical and biotech companies. More than half or our clients are small businesses. Every day we work with them to remove the barriers that stand between their discoveries and the patients who need them. We provide instant access to comprehensive capabilities for the development and manufacturing of both large and small molecule drug substances and drug products across a wide range of oral, sterile and softgel finished dosage forms.
Patheon, a part of Thermo Fisher Scientific, has state-of-the-art development and manufacturing facilities throughout North America and Europe. Formulation and process development expertise to pursue your early-phase goals and establish a scientifically sound foundation for success in later stages and beyond. What’s more, we’ve created unique solutions dedicated to helping small companies at every turn on their path to market.
Many of our midsize clients are transforming the way pharmaceuticals are developed and commercialized with a new vision of the pharma business model. Patheon is their means to make that vision into reality.
Theirs is a virtual model with ready access to the world-class facilities, technologies, talent and quality to build highly customized development and manufacturing solutions. One that provides the agility to quickly scale up or down in response to market conditions. That enables lean infrastructure and focused attention on their core strengths in discovery and marketing. It’s an outsource model that keeps them from getting mired in an overly complex supply chain of multiple specialized vendors. Ultimately we believe that midsize companies are looking for a strategic partnership with an end-to-end provider who can help them take their discovery all the way from the lab bench to the patient bedside.
Capacity. Responsiveness. Reliable quality. Those are just three of the reasons that the world’s top 20 pharmaceutical companies put their trust in our drug development and commercial manufacturing expertise.
For 40 years, we have helped large pharma to manage the ups and downs of demand, mitigate risk with redundant resources, and take advantage of opportunities in markets around the globe. As a strategic partner to the industry’s leaders, we offer innovative solutions that preserve capital and in-house resources, freeing our clients to focus on what they do best.
As generic opportunities grow increasingly complex, we offer the technical expertise, capacity and agility to capitalize opportunities. With state-of-the-art facilities, reliable on-time performance and industry-leading regulatory compliance, Patheon, a part of Thermo Fisher Scientific, will meet strict timelines and provide a dependable, high-quality supply.